Early Clinical Biometrics, Early Clinical Development, Innovative Medicines, Astrazeneca, Pepparedsleden 1, Mölndal 43183, Sweden
Currently Working in Astrazeneca.
Clinical; Respiratory; Asthma; Chronic obstructive pulmonary disease
Journal of Lung Diseases & Treatment received 247 citations as per Google Scholar report